GENENTA SCIENCE(SP.ADR)/1 (F:K5F) — Stock Price
GENENTA SCIENCE(SP.ADR)/1 (F:K5F) is currently trading at €0.52 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €0.47 and €3.68. This page tracks GENENTA SCIENCE(SP.ADR)/1's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see GENENTA SCIENCE(SP.ADR)/1 market cap and net worth.
GENENTA SCIENCE(SP.ADR)/1 (K5F) Stock Price Chart — Daily History & Trading Volume
The chart below tracks GENENTA SCIENCE(SP.ADR)/1's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
GENENTA SCIENCE(SP.ADR)/1 Income Statement — Revenue, Profit & Earnings by Year
GENENTA SCIENCE(SP.ADR)/1's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Research & Development | €2.70 Million | €4.81 Million | €6.47 Million | €5.34 Million | €3.39 Million |
| SG&A | €3.90 Million | €4.95 Million | €5.26 Million | €5.71 Million | €2.30 Million |
| Total Operating Expenses | €6.60 Million | €9.76 Million | €11.73 Million | €11.04 Million | €5.54 Million |
| Operating Income | €-6.60 Million | €-9.76 Million | €-11.73 Million | €-11.04 Million | €-5.54 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | — | — | — | — | €11.72K |
| Income Before Tax | €-6.53 Million | €-8.91 Million | €-11.65 Million | €-8.48 Million | €-5.53 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €-6.53 Million | €-8.91 Million | €-11.65 Million | €-8.48 Million | €-5.53 Million |
GENENTA SCIENCE(SP.ADR)/1 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes GENENTA SCIENCE(SP.ADR)/1's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €31.89 Million | €14.82 Million | €22.35 Million | €33.44 Million | €40.03 Million |
| Total Current Assets | €29.98 Million | €14.47 Million | €21.26 Million | €31.72 Million | €38.76 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | €22.62 Million | €8.08 Million | €15.08 Million | €0.00 | €0.00 |
| Net Receivables | — | — | — | — | — |
| Inventory | — | — | — | — | — |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €10.05 Million | €2.33 Million | €1.91 Million | €2.30 Million | €1.17 Million |
| Total Current Liabilities | €2.12 Million | €2.10 Million | €1.74 Million | €2.18 Million | €1.14 Million |
| Long-term Debt | €7.60 Million | — | — | — | — |
| Net Debt | €2.08 Million | — | — | — | — |
| Total Stockholder Equity | €21.84 Million | €12.50 Million | €20.43 Million | €31.14 Million | €38.86 Million |
| Retained Earnings | €-62.59 Million | €-56.06 Million | €-47.14 Million | €-35.47 Million | €-27.02 Million |
GENENTA SCIENCE(SP.ADR)/1 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how GENENTA SCIENCE(SP.ADR)/1 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-6.87 Million | €-6.24 Million | €-11.21 Million | €-7.42 Million | €-6.96 Million |
| Capital Expenditures | €7.62K | €4.47K | €13.79K | €27.07K | €9.01K |
| Free Cash Flow | €-6.88 Million | €-6.24 Million | €-11.22 Million | €-7.45 Million | €-6.97 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | €22.29 Million | €270.88K | €531.00 | €0.00 | €28.74 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | €1.01 Million | €847.25K | €739.88K | €722.74K | €497.10K |
| Depreciation | €28.08K | €44.52K | €42.45K | €6.14K | €4.89K |
| Change in Cash | €945.92K | €890.33K | €-26.10 Million | €-7.45 Million | €21.77 Million |
GENENTA SCIENCE(SP.ADR)/1 Earnings History — EPS Actual vs. Analyst Estimates
Track GENENTA SCIENCE(SP.ADR)/1's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for GENENTA SCIENCE(SP.ADR)/1.